WallStreetZenWallStreetZen

NASDAQ: EVOK
Evoke Pharma Inc Earnings & Revenue

EVOK past revenue growth

How has EVOK's revenue growth performed historically?
Company
106.51%
Industry
9.78%
Market
17.86%
EVOK's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
EVOK's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
EVOK's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

EVOK earnings and revenue history

Current Revenue
$5.2M
Current Earnings
-$7.8M
Current Profit Margin
-150.4%

EVOK Return on Equity

Current Company
N/A
Current Industry
15.5%
Current Market
188%

Be the first to know when EVOK announces earnings.

EVOK Return on Assets

Current Company
-91.8%
Current Industry
3.4%
EVOK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

EVOK Return on Capital Employed

Current Company
-180.83%
Current Industry
5.1%
EVOK has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

EVOK vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
EVOK$5.18M-$7.16M-$7.79M+607.36%N/A
BFRI$34.07M-$18.59M-$20.13M+6.81%N/A
PTPI$6.98M-$8.63M-$12.70M-22.43%N/A
PRFX$0.00-$9.57M-$9.34MN/AN/A
YCBD$23.45M-$17.13M-$23.98M+150.64%N/A

EVOK earnings dates

Next earnings date
May 13, 2024

Evoke Pharma Earnings & Revenue FAQ

What were EVOK's earnings last quarter?

On Invalid Date, Evoke Pharma (NASDAQ: EVOK) reported Q4 2023 earnings per share (EPS) of -$0.59, up 11.32% year over year. Total Evoke Pharma earnings for the quarter were -$1.99 million. In the same quarter last year, Evoke Pharma's earnings per share (EPS) was -$0.53.

If you're new to stock investing, here's how to buy Evoke Pharma stock.

What was EVOK's earnings growth in the past year?

As of Q1 2024, Evoke Pharma's earnings has grown year over year. Evoke Pharma's earnings in the past year totalled -$7.79 million.

What is EVOK's earnings date?

Evoke Pharma's earnings date is Invalid Date. Add EVOK to your watchlist to be reminded of EVOK's next earnings announcement.

What was EVOK's revenue last quarter?

On Invalid Date, Evoke Pharma (NASDAQ: EVOK) reported Q4 2023 revenue of $1.68 million up 110.45% year over year. In the same quarter last year, Evoke Pharma's revenue was $796.37 thousand.

What was EVOK's revenue growth in the past year?

As of Q1 2024, Evoke Pharma's revenue has grown 106.51% year over year. This is 96.73 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 9.78%. Evoke Pharma's revenue in the past year totalled $5.18 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.